Amoy Diagnostics Co., Ltd. (300685.SZ)
CNY 21.0
(-0.43%)
CNY 21.0
(-0.43%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 28.78 Million CNY | -12.35% |
| 2022 | 32.83 Million CNY | 1.76% |
| 2021 | 32.27 Million CNY | 50.56% |
| 2020 | 21.43 Million CNY | 24.89% |
| 2019 | 17.16 Million CNY | 21.99% |
| 2018 | 14.06 Million CNY | 45.01% |
| 2017 | 9.7 Million CNY | 11.59% |
| 2016 | 8.69 Million CNY | 9.16% |
| 2015 | 7.96 Million CNY | 89.91% |
| 2014 | 4.19 Million CNY | 31.55% |
| 2013 | 3.18 Million CNY | 128.82% |
| 2012 | 1.39 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 37.32 Million CNY | 12.92% |
| 2024 Q2 | 33.05 Million CNY | 4.83% |
| 2024 Q1 | 31.52 Million CNY | 9.54% |
| 2023 Q3 | 32.18 Million CNY | -5.95% |
| 2023 Q4 | 28.78 Million CNY | -10.57% |
| 2023 FY | 28.78 Million CNY | -12.35% |
| 2023 Q1 | 38 Million CNY | 15.73% |
| 2023 Q2 | 34.21 Million CNY | -9.96% |
| 2022 Q4 | 32.83 Million CNY | -28.09% |
| 2022 Q1 | 30.41 Million CNY | -5.75% |
| 2022 Q2 | 45.97 Million CNY | 51.14% |
| 2022 FY | 32.83 Million CNY | 1.76% |
| 2022 Q3 | 45.66 Million CNY | -0.66% |
| 2021 Q3 | 35.68 Million CNY | -2.17% |
| 2021 FY | 32.27 Million CNY | 50.56% |
| 2021 Q1 | 26.15 Million CNY | 22.01% |
| 2021 Q2 | 36.47 Million CNY | 39.5% |
| 2021 Q4 | 32.27 Million CNY | -9.58% |
| 2020 Q3 | 36.39 Million CNY | -15.74% |
| 2020 FY | 21.43 Million CNY | 24.89% |
| 2020 Q2 | 43.18 Million CNY | 59.15% |
| 2020 Q1 | 27.13 Million CNY | 58.13% |
| 2020 Q4 | 21.43 Million CNY | -41.11% |
| 2019 Q2 | 17.33 Million CNY | -0.1% |
| 2019 Q3 | 18.22 Million CNY | 5.1% |
| 2019 Q1 | 17.35 Million CNY | 23.36% |
| 2019 Q4 | 17.16 Million CNY | -5.81% |
| 2019 FY | 17.16 Million CNY | 21.99% |
| 2018 Q1 | 12.02 Million CNY | 23.93% |
| 2018 FY | 14.06 Million CNY | 45.01% |
| 2018 Q4 | 14.06 Million CNY | -4.16% |
| 2018 Q2 | 9.76 Million CNY | -18.77% |
| 2018 Q3 | 14.67 Million CNY | 50.3% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q3 | 9.87 Million CNY | 8.18% |
| 2017 Q4 | 9.7 Million CNY | -1.75% |
| 2017 FY | 9.7 Million CNY | 11.59% |
| 2017 Q2 | 9.12 Million CNY | 0.0% |
| 2016 FY | 8.69 Million CNY | 9.16% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 8.69 Million CNY | 0.0% |
| 2015 Q4 | 7.96 Million CNY | 0.0% |
| 2015 FY | 7.96 Million CNY | 89.91% |
| 2015 Q2 | 6.17 Million CNY | 0.0% |
| 2015 Q1 | 6.17 Million CNY | 0.0% |
| 2014 FY | 4.19 Million CNY | 31.55% |
| 2013 FY | 3.18 Million CNY | 128.82% |
| 2012 FY | 1.39 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 1.5 Billion CNY | 98.093% |
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -23.015% |
| Dirui Industrial Co.,Ltd. | 572.93 Million CNY | 94.976% |
| Beijing Strong Biotechnologies, Inc. | 229.74 Million CNY | 87.472% |
| Medicalsystem Biotechnology Co., Ltd. | 259.01 Million CNY | 88.887% |
| Maccura Biotechnology Co.Ltd | 907.48 Million CNY | 96.828% |
| Guangzhou Wondfo Biotech Co.,Ltd | 351.4 Million CNY | 91.809% |
| Guangdong Hybribio Biotech Co.,Ltd. | 99.55 Million CNY | 71.09% |
| BGI Genomics Co., Ltd. | 602.18 Million CNY | 95.22% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | 92.172% |